Genetic Regulation and Viral Pathogenesis in Microbiology

Genetic Regulation in Prokaryotes

Overview of Transcriptional Control

Transcriptional control is a primary mechanism by which bacteria and archaea regulate gene expression. This process determines when and how much of a gene product is made, allowing cells to adapt to environmental changes efficiently.

• Repression: The process by which gene expression is inhibited, often by a repressor protein binding to the operator region of DNA.

• Induction: The activation of gene expression, typically in response to a specific substrate or signal molecule.

• Positive Control: Regulatory proteins (activators) enhance transcription when bound to DNA.

• Negative Control: Regulatory proteins (repressors) inhibit transcription when bound to DNA.

Key Point: Alterations in regulatory sequences or proteins can disrupt these systems, leading to changes in gene expression.

Levels of Regulation

Cells can regulate the level of active protein at multiple stages:

• Transcriptional Regulation: Control of mRNA synthesis from DNA.

• Translational Regulation: Control of protein synthesis from mRNA.

• Post-translational Regulation: Control of protein activity via modifications, degradation, or feedback inhibition.

DNA Organization in Bacteria and Archaea

Gene Arrangement

• Bacterial and archaeal genes are typically organized without introns (non-coding sequences).

• Genes can be grouped in operons: clusters of genes transcribed together from a single promoter.

• The promoter region is a DNA sequence upstream of the gene where RNA polymerase binds to initiate transcription.

DNA-Binding Proteins

• Regulatory proteins bind to specific DNA sequences to control transcription.

• Binding can be site-specific (to a particular sequence) or nonspecific (anywhere on DNA).

• Most DNA-binding proteins interact with the major groove of DNA.

• Inverted repeats in DNA often serve as binding sites for regulatory proteins, which are frequently homodimeric (two identical subunits).

Mechanisms of Transcriptional Regulation

Initiation of Transcription

Transcription begins when RNA polymerase binds to the promoter, aided by sigma factors in bacteria. The process is terminated when the polymerase reaches a terminator sequence.

Key Terminology

• Positive Control: Activator proteins increase transcription.

• Negative Control: Repressor proteins decrease transcription.

• Inducer: Small molecule that activates gene expression.

• Corepressor: Small molecule that inhibits gene expression.

• Allosteric Regulation: Regulation of a protein by binding an effector molecule at a site other than the active site.

Examples of Regulation

• Enzyme Repression (e.g., Arginine Operon): When arginine is present, it acts as a corepressor, enabling the repressor protein to bind the operator and block transcription.

• Enzyme Induction (e.g., Lac Operon): In the presence of lactose, the inducer (allolactose) binds the repressor, preventing it from blocking transcription, thus allowing gene expression.

• Positive Control (e.g., Maltose Operon): The activator protein binds to the activator-binding site only in the presence of maltose, facilitating RNA polymerase binding and transcription.

Operons vs. Regulons

• Operon: Two or more genes transcribed into a single mRNA under the same regulatory control.

• Regulon: A set of operons and/or genes all under the control of the same regulatory protein.

Example: The maltose regulon in Escherichia coli consists of several operons regulated by the same activator protein.

Gene Regulation in Archaea

• Transcription machinery is more similar to eukaryotes, but regulatory mechanisms resemble those in bacteria.

• Archaea can both promote and block transcription using similar strategies as bacteria.

Two-Component Regulatory Systems

Mechanism

Two-component systems are widespread in bacteria and archaea, allowing cells to sense and respond to environmental changes.

• Sensor Kinase: Located in the membrane, detects environmental signals and autophosphorylates a histidine residue using ATP.

• Response Regulator: Receives the phosphate group from the sensor kinase and mediates the cellular response, often by regulating gene expression.

Example: The Pho system regulates phosphate metabolism in response to phosphate availability.

Genomic and Phyletic Distribution of TCS Components	Bacteria	Archaea	Eukarya
Genomes	899	67	55
HK (Histidine Kinase)	857	30	15
RR (Response Regulator)	862	34	15
HHK (Hybrid Histidine Kinase)	561	15	0
HRR (Hybrid Response Regulator)	258	17	0

Additional info: Table adapted from Wuichet et al. 2010 Curr Opin Microbiol. 13:1-7.

Quorum Sensing

Definition and Mechanism

Quorum sensing is the regulation of gene expression in response to fluctuations in cell population density, mediated by the accumulation of signaling molecules.

• Used by bacteria, some single-celled eukaryotes, and archaea.

• Signaling molecules (e.g., acyl-homoserine lactones, peptides) activate genes necessary for producing more signaling molecules, creating a positive feedback loop.

Advantages and Applications

• Some behaviors, such as biofilm formation and pathogenesis, are only advantageous at high cell densities.

• Quorum sensing can regulate virulence factor production, as seen in Escherichia coli.

Regulatory RNAs

Types and Functions

• Noncoding RNAs (ncRNAs): RNAs not translated into protein, including rRNAs, tRNAs, and small RNAs (sRNAs).

• Small RNAs (sRNAs): Typically 40–400 nucleotides, regulate gene expression by base pairing with target mRNAs.

Mechanisms of sRNA Activity

• Block or open ribosome binding sites (RBS) on mRNA, affecting translation.

• Alter mRNA stability by increasing or decreasing degradation by ribonucleases.

Riboswitches

• RNA elements that bind small molecules, causing conformational changes that regulate gene expression.

• Can control transcription or translation by altering RNA structure in response to ligand binding.

Viral Pathogenesis: Nipah and Influenza Viruses

Nipah Virus

• Structure: Enveloped, negative-sense RNA virus.

• Transmission: Zoonotic; can spread from animals (e.g., bats, pigs) to humans and between humans.

• Symptoms: Fever, headache, vomiting, muscle pain, cough, sore throat, difficulty breathing.

• Pathogenesis: Infects multiple organs, including the brain, lungs, and kidneys; high mortality rate (40–70%).

• Outbreaks: Occur nearly every year in parts of Asia, especially Bangladesh and India.

Influenza Virus

• Genome: Segmented, negative-sense RNA virus.

• Key Proteins: Hemagglutinin (HA) and neuraminidase (NA) are important for viral entry and release.

• Antigenic Drift: Minor changes in HA and NA due to point mutations, leading to seasonal epidemics.

• Antigenic Shift: Major changes due to reassortment of genome segments, potentially causing pandemics.

Hepatitis Viruses

Overview

Hepatitis refers to liver inflammation caused by viruses or bacteria. Viral hepatitis can lead to acute or chronic liver disease, including cirrhosis and liver failure.

Major Hepatitis Viruses

• Hepatitis A Virus (HAV): Infectious hepatitis, usually mild, transmitted fecal-oral route.

• Hepatitis B Virus (HBV): Serum hepatitis, can cause severe disease, transmitted parenterally or sexually.

• Hepatitis C Virus (HCV): Often leads to chronic infection, transmitted parenterally or sexually.

• Hepatitis D Virus (HDV): Defective virus, requires HBV for replication.

• Hepatitis E Virus (HEV): Acute, self-limiting, transmitted fecal-oral route.

Property	Hepatitis A	Hepatitis B	Hepatitis C	Hepatitis D	Hepatitis E
Common Name	Infectious	Serum	Posttransfusion non-A, non-B	Delta	Enteric non-A, non-B
Virus Structure (Family)	Naked, RNA (picornavirus)	Enveloped, DNA (hepadnavirus)	Enveloped, RNA (flavivirus)	Enveloped, RNA (deltavirus)	Naked, RNA (hepevirus)
Transmission	Fecal-oral	Parenteral, sexual	Parenteral, sexual	Parenteral, sexual	Fecal-oral
Incubation Period	Short	Long	Long	Intermediate	Short
Severity	Mild or asymptomatic	Occasionally severe	Usually subclinical	Occasionally severe	Mild, but severe in pregnant women
Mortality Rate	Very low	Low	Low	High to very high	Low, but high in pregnant women
Chronic Carrier State	No	Yes	Yes (common)	Yes	No
Other Disease Associations	None	HCC, cirrhosis	HCC, cirrhosis	Cirrhosis, fulminant hepatitis	None

Hepatitis in the United States

• Incidence of hepatitis A, B, and C has decreased significantly due to vaccination and public health measures.

• Hepatitis B and C remain major public health concerns due to chronic infection and risk of liver cancer (hepatocellular carcinoma, HCC).

• Vaccines are available for hepatitis A and B, but not for C, D, or E.

Hepatitis C and the Innate Immune System

• HCV can disrupt interferon (IFN) signaling, attenuate IFN response, and antagonize IFN-stimulated genes (ISGs), allowing persistent infection.

Summary Table: Key Regulatory Mechanisms

Mechanism	Key Feature	Example
Negative Control	Repressor blocks transcription	Arginine operon, Lac operon
Positive Control	Activator enhances transcription	Maltose operon
Two-Component System	Sensor kinase and response regulator	Pho system
Quorum Sensing	Population density-dependent regulation	Biofilm formation, virulence
Regulatory RNA	sRNA base pairing with mRNA	Translational repression/activation